Sign In
Buy CDXS
$1.40
-0.0800 (-5.41%)
At Close: Jul 31, 2026
Barclays PLC Increases Stake in Codexis, Inc. (NASDAQ:CDXS)
08:54am, Monday, 09'th Mar 2020
Barclays PLC lifted its stake in shares of Codexis, Inc. (NASDAQ:CDXS) by 272.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commiss
Fmr LLC Reduces Position in Codexis, Inc. (NASDAQ:CDXS)
08:38am, Sunday, 08'th Mar 2020
Fmr LLC trimmed its position in Codexis, Inc. (NASDAQ:CDXS) by 12.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The f
ValuEngine Downgrades Codexis (NASDAQ:CDXS) to Buy
08:08am, Wednesday, 04'th Mar 2020
Codexis (NASDAQ:CDXS) was downgraded by research analysts at ValuEngine from a “strong-buy” rating to a “buy” rating in a research report issued on Wednesday, ValuEngine reports. A number of o
Analysts Expect Codexis, Inc. (NASDAQ:CDXS) to Post -$0.03 EPS
10:18am, Tuesday, 03'rd Mar 2020
Analysts expect Codexis, Inc. (NASDAQ:CDXS) to report ($0.03) earnings per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for Codexi
Company News for Mar 2, 2020
03:15pm, Monday, 02'nd Mar 2020
Companies in the news are: ALT, BIG, W, CDXS
Codexis, Inc. (NASDAQ:CDXS) Forecasted to Earn Q3 2020 Earnings of $0.01 Per Share
08:00am, Monday, 02'nd Mar 2020
Codexis, Inc. (NASDAQ:CDXS) – Analysts at First Analysis issued their Q3 2020 earnings per share (EPS) estimates for shares of Codexis in a report released on Friday, February 28th. First Analysis a
Analysts Have Been Trimming Their Codexis, Inc. Price Target After Its Latest Report
12:19pm, Sunday, 01'st Mar 2020
It's been a sad week for Codexis, Inc. (NASDAQ:CDXS), who've watched their investment drop 17% to US$11.57 in the week...
Codexis (NASDAQ:CDXS) Stock Rating Reaffirmed by HC Wainwright
11:56am, Sunday, 01'st Mar 2020
Codexis (NASDAQ:CDXS)‘s stock had its “buy” rating reiterated by equities researchers at HC Wainwright in a research report issued on Friday, AnalystRatings.com reports. They currently have a $2
Codexis Expects Its Most Important Source of Revenue to Decline in 2020
04:15pm, Saturday, 29'th Feb 2020
The company expects a fourth straight year of stagnant product revenue -- and declining gross margin, to boot. Those are noteworthy red flags for investors.
Aviva PLC Purchases Shares of 125,682 Codexis, Inc. (NASDAQ:CDXS)
10:00am, Saturday, 29'th Feb 2020
Aviva PLC purchased a new stake in Codexis, Inc. (NASDAQ:CDXS) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional invest
Codexis (NASDAQ:CDXS) Trading Down 12.2% After Earnings Miss
07:16am, Saturday, 29'th Feb 2020
Codexis, Inc. (NASDAQ:CDXS) was down 12.2% during mid-day trading on Friday following a dissappointing earnings announcement. The stock traded as low as $10.62 and last traded at $11.65, approximately
Here's Why Codexis Fell as Much as 20.0% Today
05:52pm, Friday, 28'th Feb 2020
The enzyme engineering company reported disappointing full-year 2019 operating results.
Codexis(CDXS) Q4 2019 Earnings Call Transcript
02:01pm, Friday, 28'th Feb 2020
CDXS earnings call for the period ending December 31, 2019.
The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO
12:28pm, Friday, 28'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on Feb. 27)
Global Cord Blood Corp (...
